Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma

NCT05214183 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

81

Enrollment

NETWORK

Sponsor class

Conditions

MCL
Mantle Cell Lymphoma

Interventions

DRUG: Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma

Sponsor

Nordic Lymphoma Group

Collaborators

[object Object]